Table 2. Clinical characteristics of the patients according to MLR, NLR and PLR.
| Characteristics | MLR | NLR, median (IQR) | PLR, median (IQR) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ≤0.54 (n=174) | >0.54 (n=29) | P value | ≤4.10 (n=134) | >4.10 (n=69) | P value | ≤164.63 (n=138) | >164.63 (n=65) | P value | |||
| Age (years), median (IQR) | 65.0 (58.8–72.0) | 69.0 (63.5–78.5) | 0.028 | 65.0 (59.0–72.0) | 68.0 (63.0–75.5) | 0.094 | 65.0 (58.0–73.0) | 68.0 (62.0–73.5) | 0.080 | ||
| BMI (kg/m2), median (IQR) | 23.4 (21.5–25.7) | 22.3 (20.2–24.1) | 0.033 | 23.9 (22.0–26.0) | 22.4 (20.7–23.8) | <0.001 | 23.2 (21.7–25.4) | 23.0 (20.9–25.2) | 0.241 | ||
| Sex, n (%) | 0.933 | 0.166 | 0.875 | ||||||||
| Male | 151 (86.8) | 25 (86.2) | 113 (84.3) | 63 (91.3) | 120 (87.0) | 56 (86.2) | |||||
| Female | 23 (13.2) | 4 (13.8) | 21 (15.7) | 6 (8.7) | 18 (13.0) | 9 (13.8) | |||||
| CCI, n (%) | 0.342 | 0.091 | 0.536 | ||||||||
| ≤2 | 112 (64.4) | 16 (55.2) | 90 (67.2) | 38 (55.1) | 89 (64.5) | 39 (60.0) | |||||
| >2 | 62 (35.6) | 13 (44.8) | 44 (32.8) | 31 (44.9) | 49 (35.5) | 26 (40.0) | |||||
| T-stage, n (%) | 0.467 | 0.632 | 0.395 | ||||||||
| T1 | 72 (41.4) | 8 (27.6) | 51 (38.1) | 29 (42.0) | 54 (39.1) | 26 (40.0) | |||||
| T2 | 37 (21.3) | 6 (20.7) | 32 (23.9) | 11 (15.9) | 33 (23.9) | 10 (15.4) | |||||
| T3 | 33 (19.0) | 8 (27.6) | 26 (19.4) | 15 (21.7) | 28 (20.3) | 13 (20.0) | |||||
| T4 | 32 (18.4) | 7 (24.1) | 25 (18.7) | 14 (20.3) | 23 (16.7) | 16 (24.6) | |||||
| N-stage, n (%) | 0.595 | 0.223 | 0.131 | ||||||||
| N0 | 145 (83.3) | 23 (79.3) | 114 (85.1) | 54 (78.3) | 118 (85.5) | 50 (76.9) | |||||
| N+ | 29 (16.7) | 6 (20.7) | 20 (14.9) | 15 (21.7) | 20 (14.5) | 15 (23.1) | |||||
| M-stage, n (%) | 0.781 | 0.498 | 0.122 | ||||||||
| M0 | 166 (95.4) | 28 (96.6) | 129 (96.3) | 65 (94.2) | 134 (97.1) | 60 (92.3) | |||||
| M1 | 8 (4.6) | 1 (3.4) | 5 (3.7) | 4 (5.8) | 4 (2.9) | 5 (7.7) | |||||
| Grade, n (%) | 0.145 | 0.961 | 0.070 | ||||||||
| Low grade | 12 (6.9) | 0 (0.0) | 8 (6.0) | 4 (5.8) | 11 (8.0) | 1 (1.5) | |||||
| High grade | 162 (93.1) | 29 (100.0) | 126 (94.0) | 65 (94.2) | 127 (92.0) | 64 (98.5) | |||||
Percentages may not total 100 because of rounding. IQR, interquartile range; BMI, body mass index; CCI, comprehensive complication index; MLR, monocyte-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio.